Tandem Diabetes Care Inc.

NASDAQ: TNDM · Real-Time Price · USD
10.83
0.17 (1.59%)
At close: Aug 15, 2025, 3:59 PM
10.86
0.28%
After-hours: Aug 15, 2025, 06:17 PM EDT

Tandem Diabetes Care Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
240.68M 234.42M 282.65M 363.29M 221.91M 191.67M 196.8M 185.62M 195.92M 169.38M 220.5M 204.55M 200.26M 175.91M 210M 179.63M 172.14M 141.04M
Cost of Revenue
114.82M 116.02M 125.19M 238.64M 109.12M 97M 103.5M 95.87M 94.18M 86.48M 104.98M 100.12M 98.32M 84.81M 96.27M 82.88M 79.69M 67.75M
Gross Profit
125.86M 118.41M 157.46M 124.65M 112.79M 94.67M 93.3M 89.75M 101.73M 82.91M 115.52M 104.42M 101.95M 91.09M 113.73M 96.75M 92.45M 73.29M
Operating Income
-51.81M -120.88M -582K -26.09M -30.77M -41.68M -35.06M -31.55M -38.81M -46.47M -17.75M -47.49M -12.24M -15.34M 11.61M 7.72M 5.43M -3.24M
Interest Income
n/a n/a 4.51M 5.34M 2.82M 5.31M 5.55M 5.66M 5.78M 5.87M 3.2M 1.71M 769K 381K n/a 31K 418K 272K
Pretax Income
-57.72M -122.09M 16K -22.61M -29.74M -39.53M -31.31M -30.73M -34.63M -123.59M -16.11M -47.35M -12.95M -16.44M 11.14M 5.85M 4.07M -5.16M
Net Income
-52.4M -130.56M 755K -23.25M -30.81M -42.72M -30M -32.96M -35.77M -123.87M -15.85M -48.97M -15.06M -14.71M 10.81M 5.79M 4.01M -5.04M
Selling & General & Admin
109.6M 113.85M 105.84M 99.64M 94.24M 90.11M 85.75M 79.33M 97.61M 89.81M 97.69M 84.1M 80.61M 73.27M 71.5M 64.92M 66.52M 58.56M
Research & Development
48.12M 125.43M 52.2M 51.11M 49.33M 46.24M 42.6M 41.97M 42.93M 42.16M 35.59M 67.81M 33.57M 33.16M 29.49M 24.1M 20.5M 17.96M
Other Expenses
19.95M n/a n/a n/a n/a n/a n/a 816K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
177.66M 239.28M 158.04M 150.75M 143.57M 136.35M 128.35M 121.3M 140.54M 131.97M 133.28M 151.92M 114.19M 106.43M 100.99M 89.03M 87.02M 76.52M
Interest Expense
2.54M 1.86M 1.86M 1.86M 1.79M 1.9M 1.8M 4.84M 1.6M 1.63M 1.58M 1.58M 1.08M 1.52M 1.56M 1.51M 1.51M 1.51M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
292.49M 355.3M 283.23M 389.38M 252.68M 233.35M 231.86M 217.17M 234.72M 218.45M 238.26M 252.04M 212.5M 191.25M 197.26M 171.91M 166.71M 144.27M
Income Tax Expense
-5.32M 8.47M -739K 637K 1.07M 3.19M -1.31M 2.23M 1.15M 287K -261K 1.62M 2.11M -1.72M 337K 54K 61K -117K
Shares Outstanding (Basic)
67.05M 66.4M 65.94M 65.54M 64.99M 65.33M 65.37M 65.12M 64.83M 64.55M 64.38M 64.24M 64.08M 63.88M 63.65M 63.17M 62.72M 62.45M
Shares Outstanding (Diluted)
67.05M 66.4M 66.16M 65.54M 64.99M 65.33M 65.37M 65.12M 64.83M 64.55M 64.38M 64.24M 64.08M 63.88M 65.93M 64.78M 65.66M 62.45M
EPS (Basic)
-0.78 -1.97 0.01 -0.35 -0.47 -0.65 -0.46 -0.51 -0.55 -1.92 -0.25 -0.76 -0.23 -0.23 0.17 0.09 0.06 -0.08
EPS (Diluted)
-0.78 -1.97 0.01 -0.35 -0.47 -0.65 -0.46 -0.51 -0.55 -1.92 -0.25 -0.76 -0.23 -0.23 0.16 0.09 0.06 -0.08
EBITDA
-50.82M -116.42M 6.12M -16.54M -23.84M -33.59M -25.48M -21.87M -28.76M -118.56M -10.89M -42.27M -7.86M -11.71M 16.26M 11.12M 8.87M -170K
EBIT
-55.19M -120.73M 1.88M -20.75M -27.95M -38.38M -30.11M -26.59M -33.02M -122.51M -15.04M -45.77M -11.87M -15.36M 12.22M 6.93M 5.15M -3.65M
Depreciation & Amortization
4.37M 4.31M 4.25M 4.21M 4.11M 4.04M 4.03M 4.02M 4.26M 3.4M 3.64M 3.51M 3.55M 3.63M 3.52M 3.4M 3.44M 3.48M